Suvretta Capital Management, LLC Molecular Partners Ag Transaction History
Suvretta Capital Management, LLC
- $2.54 Billion
- Q3 2024
A detailed history of Suvretta Capital Management, LLC transactions in Molecular Partners Ag stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 400,000 shares of MOLN stock, worth $2.18 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
400,000
Previous 400,000
-0.0%
Holding current value
$2.18 Million
Previous $2.89 Million
29.6%
% of portfolio
0.08%
Previous 0.12%
Shares
1 transactions
Others Institutions Holding MOLN
# of Institutions
6Shares Held
849KCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA443KShares$2.41 Million0.07% of portfolio
-
Ubs Group Ag5.25KShares$28,5380.0% of portfolio
-
Morgan Stanley New York, NY500Shares$2,7200.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$1,4630.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $177M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...